Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
Stock Information for Acumen Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.